Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 168

The DOI matches its Crossref record.

A placebo‐controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24‐h intragastric acidity and plasma gastrin concentrations in young healthy male subjects

Williams, Sercombe, Hamilton, Pounder·1998·Alimentary Pharmacology & Therapeutics

Abstract

Background: Rabeprazole (LY307640, E3810) is a new, potent, proton pump inhibitor. A single daily 20 mg dose significantly decreases 24‐h intragastric acidity. There are no data currently available directly comparing the effect of rabeprazole on 24‐h acidity with established proton pump inhibitors. Aim: To compare the effects of rabeprazole 20 mg o.m. and omeprazole 20 mg o.m. on 24‐h intragastric acidity and plasma gastrin concentration in a randomized, double‐blind, placebo‐controlled trial, in healthy H. pylori‐negative subjects. Methods: Twenty‐four healthy male volunteers, negative for H. pylori infection by serology and 13 C‐urea breath test, were studied on the 1st and 8th day of dosing with either placebo, rabeprazole 20 mg or omeprazole 20 mg, once each morning, in a crossover fashion. On days 1 and 8, hourly intragastric acidity was measured by gastric aspiration for 24 h from 08.00 hours. On day 8, plasma gastrin concentrations were also measured hourly from 08.00 to 24.00 hours, then every 2 h thereafter. Results: A single dose of both rabeprazole and omeprazole significantly decreased 24‐h intragastric acidity compared with placebo. The 24‐h acidity on day 1 was significantly decreased for rabeprazole compared with omeprazole (331 vs. 640 mmol.h/L, P < 0.001), resulting in a significantly higher median 24‐h intragastric pH and longer times at which intragastric pH was> 3 and> 4. On day 8 of dosing, the decrease in 24‐h intragastric acidity was greater with rabeprazole than with omeprazole, but the difference was not statistically significant (160 vs. 218 mmol.h/L, P = 0.1). However, 24‐h plasma gastrin concentration (1687 vs. 1085 pmol.h/L, P < 0.01) and percentage time that intragastric pH was> 3 (69 vs. 59%, P = 0.008) and> 4 (60 vs. 51%, P = 0.03) were significantly greater. Conclusions: Rabeprazole 20 mg once daily has a significantly faster onset of antisecretory activity than omeprazole 20 mg once daily. After 8 days the differences in intragastric pH > 3 and> 4 holding times persisted, but there was no significant difference in 24‐h acidity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2036.1998.00418.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 168

Metadata

Authors
Williams, Sercombe, Hamilton, & Pounder
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
1998-11
Volume
12
Issue
11
Pages
1079-1089
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2013080155
Cited by
168
References
0
FWCI
10.70
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A placebo‐controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24‐h intragastric acidity and plasma gastrin concentrations in young healthy male subjects. https://app.cochat.ai/papers/10.1046/j.1365-2036.1998.00418.x
The paper
Williams, Sercombe, Hamilton, & Pounder. (1998). A placebo‐controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24‐h intragastric acidity and plasma gastrin concentrations in young healthy male subjects. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1046/j.1365-2036.1998.00418.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.